HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ian Bayles Selected Research

ND 322

11/2016The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ian Bayles Research Topics

Disease

2Osteosarcoma (Osteogenic Sarcoma)
10/2019 - 01/2018
2Neoplasm Metastasis (Metastasis)
01/2018 - 11/2016
1Melanoma (Melanoma, Malignant)
11/2016
1Neoplasms (Cancer)
11/2016
1Leukemia
11/2014
1Hypoxia (Hypoxemia)
01/2014

Drug/Important Bio-Agent (IBA)

2Peptide Elongation Factors (Elongation Factor)IBA
11/2014 - 01/2014
2Messenger RNA (mRNA)IBA
11/2014 - 01/2014
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2018
1Thromboplastin (Tissue Factor)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
11/2016
1ND 322IBA
11/2016
1Peptide Hydrolases (Proteases)FDA Link
11/2016
1Matrix Metalloproteinases (MMPs)IBA
11/2016
1ethylene sulfide (thiirane)IBA
11/2016
1Lysine (L-Lysine)FDA Link
11/2014

Therapy/Procedure

2Therapeutics
10/2019 - 01/2018